September’s top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business
GSK and Innoviva received positive opinion from CHMP for Trelegy Ellipta to treat COPD The European Medicines Agency’s (EMA) Committee…